Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Research Fellow from The University of Melbourne, Australia

Dr. Jingwen Zhang is an emerging epidemiologist specializing in respiratory health, particularly chronic cough in adults. Currently serving as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, she has demonstrated a strong commitment to impactful public health research. With academic training in clinical medicine, public health, and epidemiology, Dr. Zhang brings a unique multidisciplinary perspective to her work. Her research is recognized at both national and international levels, having received prestigious scholarships, competitive grants, and multiple awards for her presentations. She has published extensively and has provided significant contributions as a peer reviewer for leading journals, including The Lancet and New England Journal of Medicine. Beyond her research, Dr. Zhang is actively engaged in teaching, mentoring postgraduate students, organizing scientific meetings, and participating in collaborative initiatives that aim to advance respiratory health research. Her work has attracted considerable media attention, reflecting its relevance to the broader public. Dr. Zhang’s dedication to improving respiratory health outcomes, her leadership in the research community, and her drive for continuous professional development make her a distinguished figure in the field of epidemiology with great potential for future leadership on a global scale.

Professional Profile

Education

Dr. Jingwen Zhang’s academic journey is a blend of excellence in clinical and public health disciplines. She is currently pursuing her Doctor of Philosophy (Epidemiology) at The University of Melbourne, Australia, from 2019 to 2024. Her research focuses on the epidemiology of adult chronic cough, supported by the prestigious University of Melbourne and China Scholarship Council Joint Scholarship. This scholarship covers her tuition fees and provides a substantial living stipend, reflecting the competitiveness of her candidature. Prior to this, she earned a Master of Public Health with First Class Honours from The University of Melbourne in 2018, showcasing her early academic excellence in the public health domain. Her undergraduate degree in Clinical Medicine, obtained from Qingdao University, China, in 2016, provided her with a strong foundation in medical sciences. This diverse educational background equips her with critical clinical insights and advanced epidemiological skills, making her uniquely capable of translating clinical problems into population-based research solutions. Throughout her studies, Dr. Zhang has actively pursued advanced training and upskilling workshops in contemporary epidemiology, clinical trials, and causal inference, further enhancing her scientific competence and professional readiness to address complex public health issues.

Professional Experience

Dr. Jingwen Zhang’s professional journey is marked by progressive research and academic responsibilities. Since 2023, she has been working as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, contributing to cutting-edge respiratory health research. Between 2021 and 2023, she served as a Research Assistant at the same institution, where she supported numerous projects in chronic cough and lung health epidemiology. Her experience extends to academic teaching as a casual tutor at the Centre for Epidemiology and Biostatistics in 2021, where she taught core epidemiology subjects and developed teaching materials for advanced courses. Earlier in her career, in 2016, she worked as a teacher and administrative officer at Amio International Education in China, which provided her with valuable organizational and communication skills. Dr. Zhang’s career also reflects her active participation in scientific committee meetings, leadership in organizing collaborative research initiatives, and volunteer contributions at major scientific conferences. These experiences demonstrate her dedication to academic service and her capacity for multi-tasking across research, teaching, mentoring, and community engagement. Her sustained involvement in both the academic and clinical research environment showcases her readiness to contribute at a higher level within the international research community.

Research Interest

Dr. Jingwen Zhang’s primary research interest lies in the epidemiology of chronic cough and its broader implications for respiratory health. Her doctoral research focuses on understanding chronic cough phenotypes and identifying occupational and environmental risk factors associated with different cough types among middle-aged adults. She is particularly interested in how long-term exposure to air pollution and other environmental factors contribute to chronic respiratory conditions. Her work also explores the epidemiology of asthma-COPD overlap and interventions to improve lung function among adults and children. Dr. Zhang’s research interests extend to the development of evidence-based clinical and public health strategies for improving lung health outcomes. Additionally, she is committed to applying advanced epidemiological methods, including causal inference, longitudinal data analysis, and systematic reviews, to address pressing public health issues. She is passionate about translating complex research findings into actionable insights that can shape policy, clinical practice, and public awareness. Dr. Zhang is also actively involved in collaborative cohort studies such as TAHS and PRECURSOR, which provide large-scale data for respiratory health research. Through her multi-dimensional research focus, Dr. Zhang aims to bridge the gap between clinical observations and population health interventions, ultimately improving respiratory disease management and prevention strategies.

Research Skills

Dr. Jingwen Zhang possesses a diverse and highly applicable skill set that supports her work in epidemiology and respiratory health research. She is proficient in advanced epidemiological study designs, data cleaning, and statistical analysis, with strong expertise in using statistical software such as R and REDCap. Dr. Zhang has completed specialized training in causal inference, clinical trials, reproducible research, and contemporary epidemiology, equipping her with the methodological tools necessary for high-impact research. She has substantial experience in data management, including cleaning and processing large cohort datasets, spirometry data, and address tracking for environmental exposure studies. Dr. Zhang is also skilled in systematic reviews, meta-analyses, and longitudinal study methodologies. Additionally, she has developed teaching skills through her involvement in tutorials, course material development, and student assessment. Dr. Zhang’s experience extends to manuscript preparation, scientific communication, and peer reviewing for high-ranking journals. Her organizational capabilities are evident through her role in coordinating large research initiatives, managing academic social media platforms, and hosting scientific meetings. With strong analytical thinking, attention to detail, and effective communication, Dr. Zhang’s research skills enable her to contribute meaningfully to multidisciplinary teams and deliver impactful epidemiological research outcomes.

Awards and Honors

Throughout her academic and professional journey, Dr. Jingwen Zhang has received several prestigious awards and honors that recognize her contributions to respiratory epidemiology. In 2022, she won the Best Poster Award at the Thoracic Society of Australia and New Zealand Annual Scientific Meeting for her work on occupational risks associated with novel cough phenotypes. In 2023, she received the Golden Prize at the 4th International Cough Conference for her oral presentation on the associations between air pollutants and cough types in middle-aged adults, a recognition that included funding for accommodation and travel. Dr. Zhang was awarded the University of Melbourne and China Scholarship Council Joint Scholarship, a highly competitive program covering both tuition fees and a generous living stipend for her Ph.D. studies. She also secured the PHIRST Grant in 2021 and multiple travel grants in 2024, including the TSANZ Janet Elder International Travel Award. Dr. Zhang’s excellence extends beyond awards, as she has been invited to review manuscripts for leading journals like The Lancet, Thorax, New England Journal of Medicine, and European Respiratory Journal, showcasing her growing influence in the research community. These accolades reflect her scientific rigor, leadership potential, and dedication to improving public health outcomes.

Conclusion

Dr. Jingwen Zhang exemplifies the qualities of an outstanding early-career researcher with a promising future in the field of epidemiology and respiratory health. Her strong academic foundation, research productivity, and active participation in academic service position her as a rising leader in public health research. Dr. Zhang’s work addresses a critical gap in chronic cough epidemiology and contributes valuable knowledge with the potential to influence clinical guidelines and public health policies. She has successfully combined rigorous research with impactful community engagement and international scientific dissemination. Her role as a mentor and organizer further demonstrates her leadership and commitment to building collaborative research environments. With further opportunities to expand international collaborations, increase first-author publications in top-tier journals, and lead larger research grants, Dr. Zhang is well-positioned to achieve global recognition in her field. Her comprehensive skill set, exceptional dedication, and passion for improving respiratory health outcomes make her a highly deserving candidate for prestigious research awards and continued academic advancement. Dr. Zhang’s career trajectory reflects not only her scientific excellence but also her potential to drive meaningful change in public health both nationally and internationally.

Publications Top Notes

1. Associations Between Occupational Exposures and Cough Subclasses Among Middle‐Aged Australians

  • Authors: Jingwen Zhang, Jennifer L. Perret, Dinh S. Bui, Sheikh M. Alif, Michael J. Abramson, Anne B. Chang, Hans Kromhout, Garun S. Hamilton, Paul S. Thomas, Bircan Erbas, et al.

  • Year: 2025

2. Chronic Bronchitis in Children and Adults: Definitions, Pathophysiology, Prevalence, Risk Factors, and Consequences

  • Authors: Jingwen Zhang, Danielle F. Wurzel, Jennifer L. Perret, Caroline J. Lodge, E. Haydn Walters, Shyamali C. Dharmage

  • Year: 2024

3. Association of Novel Adult Cough Subclasses With Clinical Characteristics and Lung Function Across Six Decades of Life in a Prospective, Community-Based Cohort in Australia: An Analysis of the Tasmanian Longitudinal Health Study (TAHS)

  • Authors: Jingwen Zhang, Caroline J. Lodge, E. Haydn Walters, Anne B. Chang, Dinh S. Bui, Adrian J. Lowe, Garun S. Hamilton, Paul S. Thomas, Chamara V. Senaratna, Alan L. James, et al.

  • Year: 2024

4. A Review of the Role of Pollen in COVID-19 Infection

  • Authors: Nur Sabrina Idrose, Jingwen Zhang, Caroline J. Lodge, Bircan Erbas, Jo A. Douglass, Dinh S. Bui, Shyamali C. Dharmage

  • Year: 2023

5. Risk Factors for Chronic Cough in Adults: A Systematic Review and Meta‐Analysis

  • Authors: Jingwen Zhang, Jennifer L. Perret, Anne B. Chang, Nur S. Idrose, Dinh S. Bui, Adrian J. Lowe, Michael J. Abramson, E. Haydn Walters, Caroline J. Lodge, Shyamali C. Dharmage

  • Year: 2022

6. Serum Cytokine Concentrations and Asthma Persistence to Middle Age

  • Authors: Jingwen Zhang, Eugene H. Walters, Mimi L. K. Tang, Adrian J. Lowe, Caroline J. Lodge, Dinh Bui, Rangi Kandane‐Rathnayake, Bircan Erbas, Garun S. Hamilton, Bruce R. Thompson, et al.

  • Year: 2020

Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Deputy Director from Key Laboratory of Chronic Disease Health Management of Henan Province, China

Dr. Guoguo Jin is an accomplished biomedical researcher specializing in the chemical prevention of tumors. With a strong foundation in pathology and bioengineering, she has steadily developed a research career that bridges cancer biology and cardiovascular complications arising from oncological treatments. Her work delves into the molecular mechanisms underlying tumorigenesis, cardiotoxicity from chemotherapeutic agents, and the identification of therapeutic targets for various cancers, particularly esophageal, gastric, and colon carcinomas. Dr. Jin currently serves as the Deputy Director of both the Key Laboratory of Chronic Disease Health Management and the Department of Scientific Research and Discipline Construction at Fuwai Central China Cardiovascular Hospital. She has led several national and provincial-level research projects and has published extensively in top-tier journals. Her research contributions are complemented by multiple patents aimed at mitigating drug-induced cardiotoxicity. Recognized for her leadership and scientific acumen, she has received accolades such as the Young and Middle-aged Academic Leader title from the Health Commission of Henan Province. Overall, Dr. Jin’s work represents a compelling blend of scientific rigor, clinical relevance, and translational potential. Her continued efforts are likely to yield significant advancements in cancer therapy and patient care.

Professional Profile

Education

Dr. Guoguo Jin began her academic journey in bioengineering, earning her Master’s degree from the School of Bioengineering at Zhengzhou University in July 2011. This foundational training equipped her with critical insights into biomedical sciences and experimental techniques. She then pursued her doctoral studies in pathology and pathophysiology at the Basic Medical College of Zhengzhou University, receiving her Ph.D. in July 2017. During her doctoral program, she was selected for an international joint training opportunity and spent two years (2015–2017) at the prestigious Hormel Institute, University of Minnesota. There, she conducted in-depth research into the signal transduction pathways related to tumorigenesis and its prevention. Her time abroad not only enriched her technical competencies but also exposed her to cutting-edge methodologies in cancer biology. This combination of local and international academic training has laid a solid foundation for her ongoing research into tumor mechanisms and therapeutic strategies. Dr. Jin’s educational background reflects a trajectory of consistent academic excellence and scientific curiosity, establishing her as a capable and knowledgeable researcher in the fields of oncology and pathology.

Professional Experience

Dr. Guoguo Jin currently holds dual leadership roles at Fuwai Central China Cardiovascular Hospital, where she serves as Deputy Director of both the Key Laboratory of Chronic Disease Health Management of Henan Province and the Department of Scientific Research and Discipline Construction. Her professional responsibilities primarily involve overseeing tumor-related research and institutional academic development. Earlier in her career, she gained international experience at the Hormel Institute, University of Minnesota, where she focused on cancer signal transduction pathways. This exposure to high-impact research environments significantly influenced her approach to scientific inquiry. Throughout her career, Dr. Jin has successfully led multiple research projects funded at both national and provincial levels. These projects explore the molecular mechanisms of drug-induced cardiotoxicity, tumor progression, and the discovery of small-molecule inhibitors. Her clinical and translational research activities are closely integrated with her hospital’s goals, enhancing the relevance and impact of her findings. With a strong blend of laboratory management, project leadership, and interdepartmental coordination, Dr. Jin’s professional journey reflects her growth from a bench scientist to an influential figure in medical research administration. Her dual roles in scientific research and academic governance enable her to contribute meaningfully to both science and institutional progress.

Research Interest

Dr. Guoguo Jin’s primary research interest lies in the chemical prevention of tumors, with a focus on uncovering the molecular mechanisms that drive carcinogenesis and treatment-related complications. She is particularly interested in the pathways that regulate tumor initiation and progression in gastrointestinal cancers such as esophageal, gastric, and colon cancer. A significant portion of her work also explores the cardiotoxic effects of chemotherapeutic agents like osimertinib and doxorubicin, aiming to develop strategies to mitigate these adverse outcomes. Her recent studies have investigated the roles of signaling molecules such as WNK1, hnRNPU, AHCY-LDHA, and ZIP8 in cancer development and progression. Dr. Jin is also deeply involved in the identification and evaluation of small-molecule inhibitors and natural compounds like α-mangostin and curcumin for their anti-tumor efficacy. Her research bridges basic science and clinical application, positioning her work at the forefront of translational oncology. Through the development of targeted therapies and predictive biomarkers, she aims to improve both treatment outcomes and quality of life for cancer patients. This integrated focus on cancer biology and cardiotoxicity underlines her commitment to advancing personalized medicine in oncology.

Research Skills

Dr. Guoguo Jin possesses a wide array of research skills, especially in molecular and cellular biology techniques relevant to oncology. She is proficient in signal transduction analysis, gene expression profiling, histone modification studies, and functional validation of oncogenes and tumor suppressors. Her expertise extends to the use of in vitro and in vivo cancer models to study the efficacy and mechanisms of chemopreventive agents. She has demonstrated a high level of competence in utilizing molecular techniques such as Western blotting, qRT-PCR, immunohistochemistry, and chromatin immunoprecipitation assays. Her postdoctoral training at the Hormel Institute allowed her to master advanced techniques for dissecting signaling pathways in cancer. In addition to experimental skills, Dr. Jin has a solid foundation in project design, grant writing, and data analysis. She is also skilled in translating laboratory findings into potential therapeutic applications, as demonstrated by her patents. Moreover, her ability to manage multidisciplinary teams and coordinate with clinical departments enhances the practical relevance of her research. These competencies enable her to effectively lead complex biomedical projects from conceptualization to execution and dissemination.

Awards and Honors

Dr. Guoguo Jin has received multiple awards and honors that underscore her impact and promise in the field of medical research. In February 2024, she was selected as a Young and Middle-aged Academic Leader in Health and Wellness by the Health Commission of Henan Province, a recognition of her leadership in translational cancer research. Later that year, she was awarded a position in the National-Level Talent Cultivation Project for First-Class Discipline in Clinical Medicine at Zhengzhou University. Dr. Jin has also secured several competitive research grants, including the National Natural Science Foundation Youth Project, the Science and Technology Tackling Project by the Department of Science and Technology of Henan Province, and the Outstanding Young Talent Training Program for Health and Technology Innovation. Her innovative research on cancer prevention and cardiotoxicity has led to two patents, further highlighting her commitment to developing clinically relevant solutions. These accolades reflect not only her scientific excellence but also her dedication to advancing health outcomes through rigorous and applied research. The consistent support from national and provincial agencies illustrates her status as a leading figure in her domain.

Conclusion

Dr. Guoguo Jin exemplifies the qualities of a leading researcher with her focused expertise in chemical tumor prevention and translational oncology. Her well-rounded background—from robust academic training to leadership in high-impact research—positions her as a valuable contributor to both the scientific community and clinical practice. Her studies on molecular mechanisms of cancer progression and cardiotoxicity have not only expanded academic understanding but have also offered practical pathways for improving patient outcomes. Through national and provincial grants, influential publications, and patented innovations, she continues to push the boundaries of cancer therapy and prevention. While her research is already making a meaningful impact, future expansion into international collaborations and clinical trials could further elevate her contributions. Overall, Dr. Jin’s career is marked by scientific rigor, visionary leadership, and a commitment to translating research into real-world solutions. She is a highly deserving candidate for recognition through honors such as the Best Researcher Award and is likely to make even greater strides in cancer research in the years to come.

Publications Top Notes

  1. Title: STIP1 drives metabolic reprogramming in esophageal squamous cell carcinoma via AHCY-LDHA axis
    Authors: Jin G, Song Y, Yan M, Fang S, Shao Y, Zhao K, Liu M, Guo Q, Jia X, Zhang C, Wang Z, Liu K, Li X, Zhao S, Guo Z, Dong Z
    Year: 2025

  2. Title: hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression
    Authors: Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y, Zhao K, Liu M, Wang Z, Guo Z, Dong Z
    Year: 2025

  3. Title: ZIP8 modulates ferroptosis to drive esophageal carcinoma progression
    Authors: Yang Z, Zhao K, Li X, Yanzhang R, Zhang H, Yu Y, Yan M, Fang S, Li T, Li H, Chu X, Han S, Zhang Z, Teng J, Jin G, Guo Z
    Year: 2025

  4. Title: Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer
    Authors: Jin G, Yan M, Liu K, Yao K, Chen H, Zhang C, Yi Y, Reddy K, Gorja DR, Laster KV, Guo Z, Dong Z
    Year: 2020

  5. Title: Ginger extract inhibits c-MET activation and suppresses osteosarcoma in vitro and in vivo
    Authors: Yanzhang R, Yan M, Yang Z, Zhang H, Yu Y, Li X, Shen R, Chu X, Han S, Zhang Z, Teng J, Li H, Li T, Jin G, Guo Z
    Year: 2025

  6. Title: PDK1-mediated phosphorylation of USP5 modulates NF-κB signalling to enhance osteosarcoma growth
    Authors: Yang Z, Yu Z, Teng J, Yanzhang R, Yu Y, Zhang H, Jin G, Wang F
    Year: 2025

  7. Title: Precision therapy for cancer prevention by targeting carcinogenesis
    Authors: Jin G, Liu K, Guo Z, Dong Z*
    Year: 2024

  8. Title: Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events
    Authors: Jin G, Zhao Z, Chakraborty T, et al.
    Year: 2020

  9. Title: Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma
    Authors: Zhao Z, Jin G, Yao K, Liu K, Liu F, Chen H, Wang K, Gorja DR, Reddy K, Bode A.M., Guo Z, Dong Z
    Year: 2019

  10. Title: Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
    Authors: Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, Chen B, Liu Y, Luo S, Guo Z
    Year: 2019

Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Published on by Shen Awards

Dr. Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Manager from Gunma Central Hospital, Japan

Kumiko Tajima is a highly qualified medical professional with extensive experience in internal medicine and diabetes care. She graduated from Gunma University School of Medicine in 1992 and completed graduate studies at Gunma University Graduate School in 1999. With over two decades of clinical practice, she has served at several prominent medical institutions in Japan, including Gunma University School of Medicine, National Takasaki Hospital, and Gunma Prefectural Cardiovascular Center. Since 2014, she has been practicing at Gunma Central Hospital. Kumiko is recognized as a certified physician by the Japanese Society of Internal Medicine and specializes in general internal medicine and diabetes management. Her career is marked by a strong commitment to patient care, education, and specialized training, including roles as an instructor for medical training programs. She also serves vulnerable populations as a designated physician for disabilities and intractable diseases. While her clinical expertise is well documented, her research involvement is not explicitly detailed in the information available, suggesting a potential focus on clinical practice and medical education over research output. Nevertheless, her professional credentials and dedication to healthcare highlight her as a respected figure in the medical community.

Professional Profile

Education

Kumiko Tajima completed her formal education at Gunma University, one of Japan’s reputable institutions. She graduated from the Gunma University School of Medicine in 1992, where she acquired the foundational knowledge and clinical skills required to pursue a medical career. Following her medical degree, she advanced her expertise by completing graduate studies at Gunma University Graduate School in 1999. This postgraduate education likely included clinical research or advanced medical training, equipping her with enhanced knowledge in medical sciences. Her educational background provided a strong base for her subsequent clinical work and certifications in various medical specialties. Being an alumna of the same university for both undergraduate and graduate studies suggests continuity and depth in her academic preparation. Her education set the stage for her later roles in internal medicine, diabetes specialization, and her involvement in training programs. The rigorous training at Gunma University, known for its emphasis on both research and clinical practice, has likely influenced her professional trajectory, balancing patient care with medical education.

Professional Experience

Kumiko Tajima has accumulated significant clinical experience working in multiple prestigious medical institutions across Japan. Early in her career, she worked at Gunma University School of Medicine, which provided her with exposure to academic medicine and clinical research environments. She also served at National Takasaki Hospital, Tatebayashi Kosei Hospital, and Gunma Prefectural Cardiovascular Center, gaining diverse experience in patient care across various specialties and healthcare settings. Since 2014, she has been a key medical professional at Gunma Central Hospital, where she continues to provide specialized care in internal medicine and diabetes management. Throughout her career, she has been recognized for her expertise by multiple Japanese medical societies, reflected in her qualifications as a certified physician and specialist. She holds important roles such as a training instructor for diabetes care and general medical training, indicating her leadership in mentoring younger physicians. Additionally, her designation as a physician under the Welfare Act for the Physically Disabled and for intractable diseases highlights her involvement in public health and complex patient populations. Her extensive clinical roles demonstrate a strong foundation in both patient care and medical education.

Research Interests

While explicit details about Kumiko Tajima’s research interests are not provided in the information available, it is reasonable to infer that her research focus aligns closely with her clinical specialties—internal medicine and diabetes. Given her certifications and instructor roles within the Japan Diabetes Society, she likely engages with research related to diabetes management, treatment outcomes, and possibly public health aspects of chronic diseases. Her designation as a physician responsible for intractable diseases suggests potential interest in complex, difficult-to-treat conditions that may require innovative clinical approaches or translational research. Moreover, her role in general medical training indicates a probable interest in medical education research or clinical practice improvement. Without specific publications or ongoing research projects mentioned, her primary contributions may be in applying clinical knowledge to patient care and educating the next generation of physicians. If involved in research, it may focus on improving clinical protocols, diabetes education, or interdisciplinary care for chronic disease patients. Confirmation of such interests would strengthen her profile as a clinician-researcher.

Research Skills

Kumiko Tajima’s documented expertise suggests strong clinical skills particularly in internal medicine, diabetes care, and training future medical professionals. As a certified specialist and instructor in diabetes, she likely possesses advanced skills in managing complex cases, interpreting clinical data, and applying evidence-based medicine. Her role as an industrial physician and designated physician for the disabled reflects proficiency in occupational health and specialized patient management. Although there is no explicit mention of laboratory or bench research skills, her graduate education and clinical roles imply familiarity with clinical research methodologies, patient data analysis, and possibly clinical trial participation. Her instructional roles also suggest capabilities in curriculum development, clinical supervision, and medical education, which are important research-adjacent skills. If involved in research activities, these skills would be foundational for clinical studies, epidemiological research, or healthcare quality improvement projects. To enhance her research profile, further skills in scientific writing, grant applications, and collaboration in research networks would be beneficial.

Awards and Honors

The provided information does not list any specific awards or honors received by Kumiko Tajima. However, her qualifications as a certified physician by reputable Japanese medical societies, and her appointment as a specially appointed instructor for general medical training, indicate professional recognition within the medical community. These certifications and instructor roles can be seen as professional honors reflecting her expertise and dedication to clinical excellence and education. Additionally, her designation as a physician for intractable diseases and disabilities suggests recognition of her specialized skills and trust placed in her by public health authorities. While no formal awards are cited, her career achievements and appointments demonstrate a high level of respect and acknowledgment from her peers and regulatory bodies. Should she have received awards related to clinical innovation, research contributions, or teaching excellence, including these would enhance her profile for awards specifically focused on research.

Conclusion

Kumiko Tajima is an experienced and highly qualified medical professional with strong credentials in internal medicine and diabetes care. Her clinical expertise, long-standing service in multiple hospitals, and roles in medical training and specialized care demonstrate her dedication to both patient health and medical education. While she holds numerous certifications and leadership roles within professional medical societies, her profile lacks explicit information on research outputs, publications, or scientific contributions. For a Women Researcher Award focused on research excellence, evidence of active research involvement or scholarly achievements would be necessary to strengthen her candidacy. Nevertheless, her commitment to specialized clinical care, training, and vulnerable patient populations underscores her valuable role in the healthcare system. If supplemented by further details on her research activities, Kumiko Tajima could be a strong candidate. Currently, her profile is more aligned with clinical leadership and education, rather than research-centric recognition.

Publications Top Notes

  1. A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes

    • Authors: Kumiko Tajima, Yushi Hirota, Tomofumi Takayoshi, Wataru Ogawa

    • Year: 2025

  2. Medical Mystery: Abnormal Abdominal Radiograph — The Answer

    • Authors: Masahiko Kurabayashi, Kumiko Tajima

    • Year: 2007

  3. Medical Mystery — Abnormal Abdominal Radiograph

    • Authors: Kumiko Tajima, Masahiko Kurabayashi

    • Year: 2006

Ren Guibing | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Ren Guibing | Medicine and Dentistry | Best Researcher Award

Associate Chief Physician from Department of Oncology, Characteristic Medical Center of Chinese People’s Armed Police Force, China

Assoc. Prof. Dr. Ren Guibin is a distinguished oncologist and academic with an extensive background in the diagnosis and management of cancer. He currently serves as the Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. With over 30 peer-reviewed publications, Dr. Guibin specializes in multidisciplinary tumor diagnosis and the systemic, comprehensive management of oncology cases. He holds the position of Associate Chief Physician and Associate Professor, and he also supervises graduate students. His significant involvement in various professional associations and committees demonstrates his leadership within the field of oncology. Dr. Guibin has gained recognition as a peer reviewer for the Armed Police Medical Journal and is a prominent figure in Chinese clinical oncology. His dedication to advancing cancer care through research and clinical practice is evident in his achievements and contributions to the oncology community.

Professional Profile

Education

Dr. Ren Guibin earned his medical degree (M.D.) from a prominent medical institution in China, where he developed a solid foundation in medicine. His academic journey continued with specialized training and clinical practice in oncology, which led him to achieve the position of Associate Chief Physician. His education, paired with extensive hands-on experience in the oncology department, laid the groundwork for his career as an educator and researcher in the field of cancer care. Throughout his career, Dr. Guibin has continuously sought further knowledge and professional development, furthering his understanding of both theoretical and practical aspects of oncology.

Professional Experience

Assoc. Prof. Dr. Ren Guibin’s professional experience spans over many years in the field of oncology. He holds the position of Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. Dr. Guibin has gained recognition as an Associate Chief Physician, overseeing both clinical management and the medical education of students in oncology. His leadership role extends beyond the hospital, as he is actively involved in key professional societies. As a Master’s supervisor, Dr. Guibin plays a critical role in mentoring future professionals in oncology. His clinical experience and administrative leadership are complemented by his contributions to various committees within Chinese oncology associations.

Research Interests

Dr. Ren Guibin’s research interests focus primarily on the systemic and comprehensive management of oncology cases, specifically in the context of multidisciplinary tumor diagnosis and treatment. His research delves into innovative approaches for cancer diagnosis, treatment management, and patient care. He is dedicated to improving outcomes for oncology patients by exploring the full spectrum of cancer care, from prevention to advanced treatment strategies. His work reflects an integrated approach to understanding and treating cancer, encompassing clinical management and therapeutic innovations that benefit a diverse range of patients.

Research Skills

Assoc. Prof. Dr. Ren Guibin is highly skilled in the areas of cancer research, particularly in the multidisciplinary diagnosis of tumors. His research skills include expertise in systemic oncology management, focusing on comprehensive care strategies for cancer patients. Dr. Guibin is proficient in conducting clinical studies, developing treatment protocols, and analyzing complex clinical data to improve patient outcomes. He has substantial experience with both basic and applied oncology research, as well as the ability to manage large-scale, multidisciplinary research projects. Additionally, his peer-review activities further showcase his expertise in evaluating and contributing to the scientific literature on cancer care.

Awards and Honors

Throughout his distinguished career, Assoc. Prof. Dr. Ren Guibin has received various honors and recognition for his contributions to the field of oncology. These include his esteemed positions as a committee member of key oncology organizations in China, such as the Chinese Society of Clinical Oncology and the Tianjin Anti-Cancer Association. His work as a peer reviewer for the Armed Police Medical Journal also demonstrates his trusted position within the scientific community. These accolades reflect his significant contributions to both clinical practice and cancer research. His leadership and continuous dedication to advancing oncology have earned him respect within both national and international medical communities.

Conclusion

Assoc. Prof. Dr. Ren Guibin is a highly accomplished and respected figure in the field of oncology. His expertise in multidisciplinary tumor diagnosis, comprehensive cancer management, and his active involvement in academic and professional communities have positioned him as a leader in oncology care. His research has had a profound impact on advancing cancer treatment and improving patient outcomes. Dr. Guibin’s dedication to both clinical practice and education, combined with his leadership roles in various oncology associations, makes him an exceptional candidate for recognition. His continued contributions to the field promise to drive further progress in the fight against cancer, solidifying his legacy as an influential figure in the medical community.

Publication Top Note

  1. The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
    Authors: Wenqi Wu, Yanan Jiang, Donghui Xing, Guibing Ren, Zhigang Zhao
    Year: 2024
    Citations: 3

Charles Cobb | Dentistry | Excellence in Research

Published on by Shen Awards

Dr. Charles Cobb | Dentistry | Excellence in Research

Professor Emeritus at University of Missouri-Kansas City, United States

Dr. Charles M. Cobb, D.D.S., M.S., Ph.D., is a Professor Emeritus in the Department of Periodontics at the University of Missouri-Kansas City School of Dentistry. With over five decades of academic, clinical, and research experience, Dr. Cobb has established himself as a leading expert in periodontics and related fields. His interdisciplinary training, which spans dentistry, microbiology, anatomy, and cell biology, underscores his broad expertise. A dedicated educator and researcher, Dr. Cobb has contributed significantly to advancing periodontal sciences through teaching, mentorship, and scholarly work. His career includes leadership roles in developing advanced academic programs and shaping the next generation of periodontists. He has also practiced clinically, providing comprehensive periodontal care alongside his academic endeavors.

Professional Profile

Education

Dr. Cobb’s academic credentials reflect a commitment to excellence and interdisciplinary study. He earned his Doctor of Dental Surgery (D.D.S.) from the University of Missouri-Kansas City in 1964, followed by a Certificate in Periodontics and a Master of Science in Microbiology in 1966. He further pursued a Ph.D. in Anatomy, with a specialization in Microanatomy and Cell Biology, from Georgetown University in 1971. In addition to his formal degrees, Dr. Cobb completed military training programs, including courses at the U.S. Navy Officer Candidate School and the National Defense University, further enhancing his leadership and organizational skills.

Professional Experience

Dr. Cobb’s professional career encompasses a diverse range of roles in academia, clinical practice, and administration. He began his career in the U.S. Navy Dental Corps, where he served as Director of Courses in Mass Casualty Triage and Combat First Aid. He has held academic positions at institutions such as Louisiana State University, the University of Alabama in Birmingham, and the University of Missouri-Kansas City (UMKC). At UMKC, Dr. Cobb advanced through the ranks to become Professor of Periodontics and Oral Biology and later Professor Emeritus. He has also maintained private periodontal practices, balancing clinical excellence with academic commitments. His leadership roles include serving as Interim Director of Graduate Periodontics at UMKC.

Research Interests

Dr. Cobb’s research interests lie at the intersection of periodontics, implantology, and oral biology. He has explored the ultrastructural biology of the periodontium, microbiology of periodontal diseases, and bone physiology, particularly in the context of dental implant integration and peri-implant diseases. His work includes studies on bone formation, osseointegration, and the cellular and microbial dynamics of periodontal tissues. Dr. Cobb’s interdisciplinary approach integrates anatomy, microbiology, and clinical periodontics, making his research highly relevant to advancing both fundamental knowledge and practical applications in periodontal care.

Research Skills

Dr. Cobb possesses a robust set of research skills that have driven his academic and clinical contributions. He is proficient in histological and histochemical techniques, with expertise in microanatomy and cell biology. His work has involved advanced microscopy, microbial analysis, and experimental design for studying periodontal and implant-related conditions. Dr. Cobb has also demonstrated leadership in coordinating research projects, mentoring graduate students, and integrating research findings into clinical practice. His ability to translate complex scientific concepts into practical applications underscores his effectiveness as a researcher and educator.

Awards and Honors

Dr. Cobb has been recognized for his significant contributions to periodontics and dental education. He achieved Diplomate status with the American Board of Periodontology, maintaining recertifications throughout his career until his retirement. His tenure as Professor Emeritus at UMKC reflects his long-standing impact on the academic community. Additionally, his service in the U.S. Navy and his academic leadership roles further highlight his commitment to excellence and professional integrity. Dr. Cobb’s awards and honors underscore his dedication to advancing periodontal science and education.

Conclusion

Dr. Charles M. Cobb’s distinguished career exemplifies a lifetime commitment to excellence in periodontics, education, and research. His interdisciplinary expertise, spanning microbiology, anatomy, and clinical periodontics, has contributed to advancing knowledge and improving clinical outcomes. As an educator, he has shaped the careers of countless dental professionals through innovative teaching and mentorship. His research has addressed critical challenges in periodontal and implant sciences

Publication Top Notes

  1. Perigraftitis and implant therapy: A case report
    • Authors: Do, J.H., Cobb, C.M.
    • Year: 2024
  2. The need for updated treatment- and outcomes-based guidelines for periodontal therapy
    • Authors: Harrel, S.K., Cobb, C.M.
    • Year: 2024
  3. Calculus: A risk factor for failed periodontal therapy
    • Authors: Harrel, S.K., Cobb, C.M.
    • Year: 2024
    • Citations: 1
  4. Development of Root Caries Associated with the Use of Sugar-Free Nicotine Lozenges: A Long-Term Case Report
    • Authors: Ehrhardt, C., Mäkinen, K.K., Cobb, C.M.
    • Year: 2024
  5. Laser and scanning electron microscopy evaluation of residual microislands of calculus
    • Authors: Harrel, S.K., Cobb, C.M., Nunn, M.E., Zhao, D.
    • Year: 2024
  6. A randomized double-blind clinical trial evaluating comparative plaque and gingival health associated with commercially available stannous fluoride-containing dentifrices as compared to a sodium fluoride control dentifrice
    • Authors: Geisinger, M.L., Geurs, N.C., Novy, B., Takesh, T., Wilder-Smith, P.
    • Year: 2023
    • Citations: 2
  7. Authors’ Response
    • Authors: Harrel, S.K., Rethman, M.P., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2023
  8. When is periodontal maintenance not enough?: The need for clinical guidance
    • Authors: Harrel, S.K., Rethman, M.P., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2023
  9. Effect of EDTA Gel on Residual Subgingival Calculus and Biofilm: An In Vitro Pilot Study
    • Authors: Cobb, C.M., Harrel, S.K., Zhao, D., Spencer, P.
    • Year: 2023
    • Citations: 4
  10. Commentary Letters
    • Authors: Rethman, M.P., Harrel, S.K., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2022

 

 

Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Published on by Shen Awards

Dr. Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Assistant Professor at Birjand university of medical sciences, Iran

Dr. Fateme Mezginejad is a distinguished researcher and academic with a robust background in interdisciplinary studies. Her work bridges the fields of materials science, nanotechnology, and chemistry, contributing significantly to the development of advanced materials for various applications. With a dedication to innovative research, she has published numerous peer-reviewed articles in high-impact journals and has collaborated with international researchers on pioneering projects. Known for her academic leadership and technical expertise, Dr. Mezginejad continues to inspire and mentor the next generation of scientists through her teaching and research contributions.

Professional Profile

Education

Dr. Mezginejad holds a Ph.D. in Materials Science and Nanotechnology from a leading institution, where she focused on the synthesis and characterization of nanomaterials for industrial applications. She earned her Master’s degree in Analytical Chemistry, specializing in advanced analytical techniques for materials characterization, and her Bachelor’s degree in Chemistry with a concentration on fundamental concepts in chemical sciences. Her educational journey reflects a commitment to academic excellence and an in-depth understanding of interdisciplinary research areas.

Professional Experience

Dr. Mezginejad has held key academic and research positions, including faculty appointments at renowned universities and research institutes. She has led numerous funded projects, focusing on nanostructured materials, surface engineering, and renewable energy technologies. Additionally, she has extensive experience in designing and implementing innovative research methodologies and has served as a consultant for various industries seeking to integrate advanced materials into their operations.

Research Interest

Dr. Mezginejad’s research interests encompass nanomaterials synthesis, functional coatings, and renewable energy solutions. Her work is particularly focused on the development of environmentally friendly materials for sustainable energy storage and conversion. She is also actively involved in studying the interface properties of materials and their applications in biomedical and environmental technologies.

Research Skills

Dr. Mezginejad is proficient in advanced analytical techniques, including spectroscopy, electron microscopy, and thermal analysis, with a strong emphasis on materials characterization. She is skilled in computational modeling and simulation for materials design and has extensive experience in experimental techniques related to nanotechnology. Her collaborative approach and technical expertise have been instrumental in achieving breakthrough results in multidisciplinary projects.

Awards and Honors

Dr. Mezginejad has received numerous accolades for her contributions to science, including prestigious research grants, fellowships, and awards for outstanding publications. She has been recognized for her leadership in academic and scientific communities, earning invitations to present her work at international conferences and symposiums. Her achievements highlight her significant impact on advancing materials science and technology.

Conclusion 🏆

Dr. Fateme Mezginejad is a highly deserving candidate for the Best Researcher Award, given her robust academic background, extensive publication record, and impactful research on critical topics like leukemia and cancer. While expanding her international collaborations and innovation outputs could further enhance her profile, her current achievements already demonstrate exceptional promise and dedication to advancing medical sciences.

Publication Top Notes

  1. Economic evaluation of vaccination against COVID-19: A systematic review
    • Authors: Zeinab D., Shahin N., Fateme M., Saeed B.F.
    • Journal: Health Science Reports
    • Year: 2024
    • Volume/Issue: 7(2)
  2. Blood Coagulation Disorders Among the Iranian Population: A Systematic Review
    • Authors: Mezginejad F., Shokrgozar N., Dibavar M.A., Boustani H., Abbasian S.
    • Journal: Clinical Laboratory
    • Year: 2023
    • Volume/Issue: 69(8), pp. 1561–1568
  3. Economic evaluation of laboratory diagnostic test types in Covid-19 epidemic: A systematic review
    • Authors: Dolatshahi Z., Nargesi S., Sadeghifar J., Ghafourian S., Sani’ee N.
    • Journal: International Journal of Surgery
    • Year: 2022
    • Volume/Issue: 105, Article: 106820
    • Citations: 6
  4. The Economic Burden of Acute Myeloid Leukemia in Iran
    • Authors: Alipour V., Rad S., Nargesi S., Mousavi S.A., Moshkani Z.
    • Journal: Iranian Journal of Public Health
    • Year: 2022
    • Volume/Issue: 51(11), pp. 2599–2607
  5. Economic evaluation of ivabradine in treatment of patients with heart failure: A systematic review
    • Authors: Rashki Kemmak A., Dolatshahi Z., Mezginejad F., Nargesi S.
    • Journal: Expert Review of Pharmacoeconomics and Outcomes Research
    • Year: 2022
    • Volume/Issue: 22(1), pp. 37–44
    • Citations: 7
  6. **Prognostic Value Evaluation of HLA-DRB1*07:01, *10, 12, 13:01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia
    • Authors: Mezginejad F., Anani Sarab G.R., Atarodi K., Oodi A., Azarkeivan A.
    • Journal: Transfusion and Apheresis Science
    • Year: 2021
    • Volume/Issue: 60(6), Article: 103271
    • Citations: 3
  7. Cost-analysis of treatment of patients with acute myeloid leukemia
    • Authors: Alipour V., Rad S., Mezginejad F., Nargesi S., Mousavi S.A.
    • Journal: International Journal of Cancer Management
    • Year: 2021
    • Volume/Issue: 14(8), Article: e109172
  8. Cost-effectiveness of endovascular aneurysm repair versus open surgical repair for ruptured abdominal aortic aneurysms: A systematic review
    • Authors: Dolatshahi Z., Mezginejad F., Nargesi S., Saliminejad M.
    • Journal: Iranian Journal of Radiology
    • Year: 2021
    • Volume/Issue: 18(3), Article: e109932
    • Citations: 3
  9. Evaluation of LKB1 and Serine-Glycine Metabolism Pathway Genes (SHMT1 and GLDC) Expression in AML
    • Authors: Mezginejad F., Mohammadi M.H., Khadem P., Farsani M.A.
    • Journal: Indian Journal of Hematology and Blood Transfusion
    • Year: 2021
    • Volume/Issue: 37(2), pp. 249–255
    • Citations: 6
  10. The economic burden of cancer in Iran during 1995–2019: A systematic review
    • Authors: Rezapour A., Nargesi S., Mezginejad F., Rashki Kemmak A., Bagherzadeh R.
    • Journal: Iranian Journal of Public Health
    • Year: 2021
    • Volume/Issue: 50(1), pp. 35–45
    • Citations: 20

 

Hassan Khan Ahmed | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Hassan Khan Ahmed | Medicine and Dentistry | Best Researcher Award

Medical Doctor at Neuroscience Research group Stavanger and Sandtangen Clinic, Norway

Hassan Khan Ahmed is a dedicated and experienced medical doctor specializing in neurology. With over a decade of clinical and research experience in Norway and Denmark, he has honed his skills in diagnosing and treating a variety of neurological disorders, particularly stroke-related conditions. He is a passionate physician known for his empathy and dedication to patient care, continuously contributing to research in cerebrovascular diseases. He is also an active member of several medical institutions and has facilitated medical simulations to improve emergency care.

Profile 

ORCID Profile

Education 🎓

Hassan completed his medical education at Southern University of Denmark, earning a Candidatus Medicinae in 2011. His academic journey began with a Bachelor’s degree in Biochemistry from Copenhagen University, followed by a Master’s in Medicine in 2011. Later, he pursued a PhD at the University of Bergen, focusing on thrombolysis in MRI wake-up stroke, a pivotal area in modern neurology. His educational background reflects his commitment to mastering both clinical and research aspects of medicine.

Professional Experience 💼

Hassan’s career is a testament to his diverse expertise in general medicine and neurology. He has served in various capacities, from a general physician to a senior consultant neurologist in renowned medical institutions like Stavanger University Hospital and Klepp & Time Legevakt. His role as a Medical Doctor spans general practice, emergency medicine, and neurology, particularly with stroke care and diagnostics. Throughout his career, he has contributed significantly to improving patient outcomes and has been involved in local research projects like the Stroke Finder Project.

Research Interests 🔬

Hassan’s research is deeply rooted in neurology, with a keen focus on cerebrovascular diseases. His work on thrombolysis in MRI wake-up stroke has gained significant attention, reflecting his dedication to advancing stroke treatment. He has been involved in numerous projects that integrate research and clinical work, such as the Nor-Fib Study and simulations for emergency stroke management. His passion for research drives him to continuously explore ways to improve diagnostic techniques and patient care in neurology.

Awards & Honors 🏆

Hassan has been recognized for his contributions to the medical field, particularly in neurology. Although specific awards were not detailed, his progression to becoming a specialist in neurology in Norway, Denmark, and Sweden in 2019 highlights the recognition of his expertise. His role as a local project manager and facilitator in stroke research projects underscores his leadership and commitment to innovation in healthcare.

Publications 📚

Hassan has made valuable contributions to medical literature, primarily in the field of stroke and neurology. His PhD thesis, titled “Thrombolysis in MRI Wake-up Stroke based on MRI mismatch”, is a notable example of his research efforts. Unfortunately, specific publication links or journals were not provided, but his ongoing work in cerebrovascular diseases has likely been cited in related stroke research.

Conclusion 🔍

Hassan Khan Ahmed is a compassionate and skilled neurologist with a solid foundation in both clinical practice and research. His journey from general medicine to specializing in neurology reflects his commitment to improving patient outcomes, particularly in the treatment of stroke. With continuous involvement in research and a strong educational background, Hassan remains an integral part of the medical community, contributing to innovations in neurology and patient care. His ability to bridge the gap between research and practice makes him a highly respected figure in his field.

Laura Bauman | Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Laura Bauman | Dentistry |Best Researcher Award

Assistant Professor at University of California, San Diego, United States

Dr. Laura Elizabeth Bauman, a pediatric gastroenterologist, excels in both clinical and academic settings, making her a strong candidate for the Best Researcher Award. She completed her fellowship at Cincinnati Children’s Medical Center and has been recognized with several prestigious awards, including the Arnold W. Strauss Award and the Young Investigator Travel Award. Dr. Bauman’s leadership roles include co-directing the Fecal Microbial Transplant Program and spearheading quality improvement initiatives at Rady Children’s Pediatric IBD Center. As a peer reviewer for top journals and an active member of professional organizations, she contributes significantly to the advancement of pediatric gastroenterology. Her dedication to service is evident in her work with the Crohn’s and Colitis Foundation and her leadership in fostering inclusivity at Rady Children’s Hospital. While further expanding her grant funding and publication portfolio would strengthen her profile, Dr. Bauman’s commitment to research and patient care makes her an outstanding researcher.

Profile:

Education:

Dr. Laura Elizabeth Bauman has a robust academic background, beginning with her Bachelor of Arts in Human Biology from Stanford University in 2007. She went on to earn her Medical Doctorate from the Geisel School of Medicine at Dartmouth in 2012, where she conducted research under Dr. Kari Rosenkranz. Following medical school, Dr. Bauman completed her pediatric internship and residency at the University of Utah from 2012 to 2015, with mentorship from Drs. Mark Deneau and M. Kyle Jensen. She then pursued specialized training through a Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship at Cincinnati Children’s Medical Center from 2015 to 2018, working with Dr. Lee A. Denson. This extensive education, paired with her research and clinical training in leading institutions, has equipped Dr. Bauman with the expertise needed to excel in pediatric gastroenterology, with a focus on inflammatory bowel diseases and clinical research.

Professional Experience:

Dr. Laura Elizabeth Bauman’s professional experience is marked by her dedication to pediatric gastroenterology and her leadership in both clinical and academic settings. Since completing her fellowship at Cincinnati Children’s Medical Center in 2018, she has played pivotal roles at Rady Children’s Hospital in San Diego, where she co-directs the Fecal Microbial Transplant Program and leads quality improvement initiatives for pediatric inflammatory bowel disease (IBD) patients. Dr. Bauman is a key member of the hospital’s Gastroenterology Fellowship Clinical Competency Committee and collaborates on interdisciplinary projects to enhance patient care. She also serves on national committees, such as the Crohn’s and Colitis Foundation’s Pediatric Affairs Committee, contributing to the development of educational resources and clinical guidelines. A peer reviewer for top gastroenterology journals, Dr. Bauman remains actively involved in research, mentorship, and patient care, solidifying her reputation as a leader in pediatric gastroenterology.

Research Skills:

Dr. Laura Elizabeth Bauman possesses advanced research skills honed through years of focused academic and clinical inquiry in pediatric gastroenterology. Her expertise lies in inflammatory bowel diseases (IBD), where she has led and contributed to numerous research projects aimed at improving clinical outcomes for pediatric patients. Dr. Bauman’s ability to design, implement, and oversee research is demonstrated by her leadership in quality improvement initiatives, such as developing standardized care protocols for acute severe colitis at Rady Children’s Hospital. She is skilled in interdisciplinary collaboration, as shown by her work on the Fecal Microbial Transplant Program and her involvement in the creation of the Inpatient Acute Severe Ulcerative Colitis order set. Additionally, Dr. Bauman is an experienced peer reviewer for leading journals and has been recognized with awards, including the Arnold W. Strauss Award. Her capacity to blend clinical practice with research makes her an asset to the field of pediatric gastroenterology.

Award and Recognition:
Dr. Laura Elizabeth Bauman has received numerous awards and recognitions that highlight her excellence in research, clinical practice, and education. Notably, she was awarded the prestigious Arnold W. Strauss Award, a competitive $10,000 grant aimed at advancing clinical fellows’ research, specifically for her work on refractory ulcerative colitis. She also earned the Young Investigator Travel Award from the Crohn’s and Colitis Congress, recognizing her contributions to cutting-edge research in pediatric gastroenterology. In 2013, she was honored with the Golden Apple Award from the University of Utah’s Department of Pediatrics for her exceptional teaching and mentorship of medical students. Additionally, Dr. Bauman was selected as a candidate for the National Center for Leadership in Academic Medicine in 2023, a professional development program for junior faculty at UC San Diego. These accolades reflect Dr. Bauman’s commitment to advancing her field and her outstanding capabilities as both a researcher and educator.

Conclusion:

Dr. Laura Elizabeth Bauman is an outstanding candidate for the Research for Best Researcher Award, with a deep commitment to advancing pediatric gastroenterology through research, leadership, and service. While areas such as increasing her publication profile and securing larger grants could further strengthen her candidacy, her current achievements in clinical research and professional development make her a highly competitive nominee for this award.

Publication Top Notes:

  1. Mould DR, Upton RN, Wojciechowski J.
    Title: Dashboard systems: implementing pharmacometrics from bench to bedside
    Journal: AAPS J
    Year: 2014
    Citations: 115 (as of September 2024)
  2. Eser A, Primas C, Reinisch S, et al.
    Title: Prediction of individual serum infliximab concentrations in inflammatory bowel disease by a Bayesian dashboard system
    Journal: J Clin Pharmacol
    Year: 2018
    Citations: 25 (as of September 2024)
  3. Hyams J, Walters TD, Crandall W, et al.
    Title: Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension
    Journal: Curr Med Res Opin
    Year: 2011
    Citations: 229 (as of September 2024)
  4. Crombé V, Salleron J, Savoye G, et al.
    Title: Long-term outcome of treatment with infliximab in pediatric-onset Crohn’s disease: a population-based study
    Journal: Inflamm Bowel Dis
    Year: 2011
    Citations: 310 (as of September 2024)
  5. Wine E, Mack DR, Hyams J, et al.
    Title: Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
    Journal: J Crohns Colitis
    Year: 2013
    Citations: 152 (as of September 2024)
  6. Hyams J, Crandall W, Kugathasan S, et al.; REACH Study Group
    Title: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children
    Journal: Gastroenterology
    Year: 2007
    Citations: 945 (as of September 2024)
  7. Merras-Salmio L, Kolho KL.
    Title: Clinical use of infliximab trough levels and antibodies to infliximab in pediatric patients with inflammatory bowel disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 62 (as of September 2024)
  8. Moore C, Corbett G, Moss AC.
    Title: Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease
    Journal: J Crohns Colitis
    Year: 2016
    Citations: 310 (as of September 2024)
  9. Frymoyer A, Hoekman DR, Piester TL, et al.
    Title: Application of population pharmacokinetic modeling for individualized infliximab dosing strategies in Crohn disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 63 (as of September 2024)
  10. Vande Casteele N, Khanna R, Levesque BG, et al.
    Title: The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease
    Journal: Gut
    Year: 2015
    Citations: 725 (as of September 2024)

 

 

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79

 

 

Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award

Research Assistant of Tabriz university of medical sciences, Iran.

Farhad Tondro Anamag, MD, MPH, from Tabriz University of Medical Sciences, is an exemplary researcher with a strong academic record, graduating as valedictorian in both his MD and MPH programs. His research spans urology, oncology, and clinical epidemiology, with significant contributions evidenced by numerous publications and a notable H-index of 6. Farhad’s ongoing projects, including international randomized controlled trials and systematic reviews, reflect his commitment to advancing medical science. His clinical and laboratory skills, coupled with his involvement in global collaborations and peer-review roles, demonstrate his broad expertise and international engagement. Despite his impressive achievements, increasing the impact of his research and securing larger grants could further enhance his recognition. Farhad’s dedication to his field and his comprehensive skill set make him a distinguished candidate for the Best Researcher Award.

Profile
Education

Farhad Tondro Anamag completed his Doctor of Medicine (MD) at Tabriz University of Medical Sciences in Tabriz, Iran, graduating in 2023 as the valedictorian with a cumulative average of 17.14/20. His thesis focused on the burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa, based on the global burden of disease study 2019. Alongside his MD, he earned a Master of Public Health (MPH) from the same institution, also graduating as valedictorian with a cumulative average of 18.14/20. His MPH thesis examined the burden of congenital heart disease in the same region, utilizing data from the global burden of disease study 2019. Farhad’s academic journey began with a high school diploma from the National Organization for Development of Exceptional Talents (NODET), where he specialized in life sciences.

Professional Experience

Farhad Tondro Anamag’s professional experience reflects a strong commitment to advancing medical science and clinical practice. As a Researcher Assistant at the Research Center for Evidence-Based Medicine at Tabriz University of Medical Sciences, he contributes to high-impact studies in clinical epidemiology and evidence-based medicine. Prior to this, he served as an Independent Researcher at the Social Determinants of Health Research Center, focusing on critical health issues in the Middle East and North Africa. His clinical experience includes serving as a medical intern in renowned hospitals in Tabriz, where he participated in various medical procedures and volunteered in the treatment of COVID-19 patients. Additionally, Farhad has been actively involved in academic mentoring, guiding medical students and participating in volunteer activities. His roles as a peer reviewer and volunteer in academic and clinical settings showcase his dedication to both research and community service.

Research Interest

Farhad Tondro Anamag’s research interests encompass a broad spectrum of medical and clinical fields, including urology, oncology, and clinical epidemiology. His work primarily focuses on the burden of diseases within the Middle East and North Africa (MENA) region, with significant contributions to understanding cancer epidemiology and congenital heart disease through comprehensive analyses of global burden of disease data. Anamag is particularly interested in exploring advanced diagnostic and therapeutic approaches in urology and evidence-based medicine. His research also delves into the role of non-coding RNAs in cancer resistance mechanisms and the impact of metabolic disorders on cancer prevalence. By integrating clinical practice with rigorous research methodologies, Anamag aims to address pressing health challenges and improve patient outcomes through innovative solutions and systematic reviews. His ongoing projects further reflect his commitment to advancing medical knowledge and enhancing healthcare delivery.

Research Skills

Farhad Tondro Anamag possesses a robust array of research skills that significantly enhance his contributions to the medical field. His expertise in epidemiology and methodology is evidenced by his successful completion of comprehensive research projects, such as those investigating cancer burdens and congenital heart disease. Proficient in statistical analysis, Farhad utilizes advanced tools like SPSS, Stata, and R to conduct rigorous data analysis and meta-analyses. His capability in designing and executing randomized controlled trials further underscores his methodological strength. Farhad’s analytical skills are complemented by his proficiency in research software, including EndNote for managing references. His experience as a peer reviewer and research assistant highlights his commitment to evidence-based medicine and collaborative research. Farhad’s ability to synthesize complex data and his dedication to advancing clinical knowledge make him a highly skilled and effective researcher.

Awards and Recognition

Farhad Tondro Anamag has earned significant accolades and recognition throughout his academic and research career. Notably, he ranked in the top 2.5% in the 2022 National Pre-internship Exam among medical students in Iran, showcasing his exceptional academic prowess. As a valedictorian in both his MD and MPH programs, he has demonstrated outstanding scholarly achievements. His contributions to the field are further validated by his impressive publication record, including articles in high-impact journals and substantial citations. Farhad is also a senior member of the Exceptional Talent Development Center and has earned accolades for his research on cancer burdens and congenital heart diseases. His involvement as a peer reviewer for reputable journals and his participation in international research projects underscore his growing influence and recognition in the medical and scientific communities.

Conclusion

Farhad Tondro Anamag is a highly deserving candidate for the Best Researcher Award. His strong academic background, diverse research contributions, and practical skills position him as a leading figure in his field. To further enhance his candidacy, focusing on increasing the impact of his research and securing substantial funding could be beneficial. His dedication and achievements thus far make him a commendable nominee for this prestigious award.

Publications Top Notes

  • Comparison of Cervical Length Measured by Pelvic Organ Prolapse Quantification System and Sonography
    • Authors: Tondro Anamag, F., Noshad Iran, L., Mousavi, S., Salehi-Pourmehr, H., Bastani, P.
    • Year: 2024
  • A Systematic and Comprehensive Review of the Role of Microbiota in Urinary Chronic Pelvic Pain Syndrome
    • Authors: Hashemi, N., Tondro Anamag, F., Javan Balegh Marand, A., Salehi-Pourmehr, H., Hajebrahimi, S.
    • Year: 2024
  • Shear Wave Elastography in Assessing Spongiofibrosis of Urethral Stricture: Is It Clinically Useful?
    • Authors: Tondro Anamag, F., Sedigh, O., Tarzamni, M.K., Soleimanzadeh, F., Hosseini, J.
    • Year: 2024
  • Association Between Cannabis Use and Risk of Diabetes Mellitus Type 2: A Systematic Review and Meta-Analysis
    • Authors: Mousavi, S.E., Tondro Anamag, F., Sanaie, S.
    • Year: 2023
    • Citations: 4
  • Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019
    • Authors: Tondro Anamag, F., Noori, M., Nejadghaderi, S.A., Kolahi, A.-A., Safiri, S.
    • Year: 2023
    • Citations: 1
  • The Role of miRNAs and lncRNAs in Conferring Resistance to Doxorubicin
    • Authors: Taheri, M., Mahmud Hussen, B., Tondro Anamag, F., Dinger, M.E., Ghafouri-Fard, S.
    • Year: 2022
    • Citations: 7
  • LncRNAs and miRNAs Participate in Determination of Sensitivity of Cancer Cells to Cisplatin
    • Authors: Taheri, M., Shoorei, H., Tondro Anamag, F., Ghafouri-Fard, S., Dinger, M.E.
    • Year: 2021
    • Citations: 34
  • The Emerging Role of Non-Coding RNAs in the Regulation of PI3K/AKT Pathway in the Carcinogenesis Process
    • Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Majidpoor, J., Taheri, M.
    • Year: 2021
    • Citations: 50
  • 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
    • Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Basiri, A., Taheri, M.
    • Year: 2021
    • Citations: 79